$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] Intensive care during the 2019-coronavirus epidemic
Cuidados intensivos durante la epidemia de coronavirus 2019 원문보기

Medicina intensiva, v.44 no.6, 2020년, pp.351 - 362  

González-Castro, A. (Servicio de Medicina Intensiva, Hospital Universitario Marqué) ,  Escudero-Acha, P. (s de Valdecilla, Santander) ,  Peñasco, Y. (Servicio de Medicina Intensiva, Hospital Universitario Marqué) ,  Leizaola, O. (s de Valdecilla, Santander) ,  Martínez de Pinillos Sánchez, V. (Servicio de Medicina Intensiva, Hospital Universitario Marqué) ,  García de Lorenzo, A. (s de Valdecilla, Santander)

Abstract AI-Helper 아이콘AI-Helper

Abstract On 31 December 2019, the Health Commission of Hubei Province of China first unveiled a group of unexplained cases of pneumonia, which WHO subsequently defined as the new coronavirus of 2019 (SARS-CoV-2). SARS-CoV-2 has presented rapid person-to-person transmission and is currently a global...

주제어

참고문헌 (72)

  1. 1 Centre for Health Protection of the Hong Kong Special Administrative Region Government. CHP closely monitors cluster of pneumonia cases on Mainland. Dec 31, 2019. https://www.info.gov.hk/gia/general/201912/31/P2019123100667.htm. [consultada el 26 de febrero de 2020]. 

  2. 2 Fuk-Woo Chan J. Yuan S. Kin-Hang Kai-Wang K. Chu H. Yang J. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster Lancet 395 2020 514 523 10.1016/S0140-6736(20)30154-9 31986261 

  3. 3 Centre for Health Protection of the Hong Kong Special Administrative Region Government. CHP provides further information on cluster of pneumonia cases in Wuhan. Jan 12, 2020. https://www.info.gov.hk/gia/general/202001/12/P2020011200710.htm. [consultada el 26 de febrero de 2020]. 

  4. 4 Ministerio de Sanidad del Gobierno de España. https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov-China/documentos/Actualizacion_43_COVID-19.pdf. [consultado el 13 de marzo de 2020]. 

  5. 5 Zhu N. Zhang D. Wang W. Li X. Yang B. Song J. China Novel Coronavirus Investigating and Research Team.A novel coronavirus from patients with pneumonia in China, 2019 N Engl J Med 382 2020 727 733 10.1056/NEJMoa2001017 31978945 

  6. 6 Chen N. Zhou M. Dong X. Qu J. Gong F. Han Y. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: descriptive study Lancet 395 2020 507 513 10.1016/S0140-6736(20)30211-7 32007143 

  7. 7 Li Fang Structure, Function, and Evolution of Coronavirus Spike Proteins Ann Rev Virol 3 2016 237 261 10.1146/annurev-virology-110615-042301 27578435 

  8. 8 Wan Y. Shang J. Graham R. Baric R.S. Li F. Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS J Virol. 2020 10.1128/JVI.00127-20 

  9. 9 Wan Y. Shang J. Graham R. Baric R.S. Li F. Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS J Virol 2020 10.1128/JVI.00127-20 

  10. 10 Li Q. Guan X. Wu P. Wang X. Zhou L. Tong Y. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia N Engl J Med. 2020 10.1056/NEJMoa200131 

  11. 11 Linton N.M. Kobayashi T. Yang Y. Hayashi K. Akhmetzhanov A.R. Jung S.M. Incubation period and other epidemiological characteristics of 2019 novel coronavirus infections with right truncation: a statistical analysis of publicly available case data J Clin Med 17 2020 9 10.3390/jcm9020538 

  12. 12 Rothe C. Schunk M. Sothmann P. Bretzel G. Froeschl G. Wallrauch C. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany N Engl J Med. 2020 10.1056/NEJMc2001468 

  13. 13 Callaway E. Cyranoski D. China coronavirus: six questions scientists are asking Nature 577 2020 605 607 10.1038/d41586-020-00166-6 31992880 

  14. 14 Zhang J. Zhou L. Yang Y. Peng W. Wang W. Chen X. Therapeutic and triage strategies for 2019 novel coronavirus disease in fever clinics Lancet Respir Med 8 2020 e11 2 10.1016/S2213-2600(20)30071-0 32061335 

  15. 15 Grasselli G. Pesenti A. Cecconi M. Utilización de cuidados críticos para el brote de COVID-19 en Lombardía, Italia : experiencia temprana y pronóstico durante una respuesta de emergencia JAMA 2020 10.1001/jama.2020.4031 

  16. 16 Parodi S.M. Liu V.X. De la contención a la mitigación de COVID-19 en los EE. UU JAMA 2020 10.1001/jama.2020.3882 

  17. 17 Christian M.D. Sprung C.L. King M.A. Dichter J.R. Kissoon N. Devereaux A.V. Triage: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement Chest 146 2014 e61S 74S 10.1378/chest.14-0736 25144591 

  18. 18 Covid-19: How to triage effectively in a pandemic. https://blogs.bmj.com/bmj/2020/03/09/covid-19-triage-in-a-pandemic-is-even-thornier-than-you-might-think/?utm_campaign=shareaholic&utm_medium=twitter&utm_source=socialnetwork. [Acceso el 10 de marzo de 2020]. 

  19. 19 Huang C. Wang Y. Li X. Ren L. Zhao J. Hu Y. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Lancet 395 2020 497 506 10.1016/S0140-6736(20)30183-5 31986264 

  20. 20 Song F. Shi N. Shan F. Zhang Z. Shen J. Lu H. Emerging coronavirus 2019-nCoV pneumonia Radiology. 6 2020 200274 10.1148/radiol.2020200274 

  21. 21 Chen L. Liu H.G. Liu W. Liu J. Liu K. Shang J. Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia Zhonghua Jie He He Hu Xi Za Zhi. 43 2020 E005 10.3760/cma.j.issn.1001-0939.2020.0005 32026671 

  22. 22 Wang D. Hu B. Hu C. Zhu F. Liu X. Zhang J. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China JAMA 2020 10.1001/jama.2020.1585 

  23. 23 Remuzzi A. Remuzzi G. COVID-19 and Italy: what next? Lancet 2020 10.1016/S0140-6736(20)30627-9 

  24. 24 Lippi G. Plebani M. Procalcitonin in patients with severe coronavirus disease 2019(COVID-19): a meta-analysis Clinica Chimica Acta 2020 10.1016/j.cca.2020.03.004 

  25. 25 Lippi G. Plebani M. Laboratory abnormalities in patients with COVID-2019 infection Clin Chem Lab Med 2020 https://doi:/10.1515/cclm-2020-0198 

  26. 26 Higgins J.P. Thompson S.G. Deeks J.J. Altman D.G. Measuring inconsistency in metaanalyses BMJ 327 2003 557 560 10.1136/bmj.327.7414.557 12958120 

  27. 27 Zhang J. Zhou L. Yang Y. Peng W. Wang W. Chen X. Therapeutic and triage strategies for 2019 novel coronavirus disease in fever clinics Lancet Respir Med 8 2020 e11 e12 10.1016/S2213-2600(20)30071-0 32061335 

  28. 28 Wu C. Chen X. Cai Y. Xia J. Zhou X. Xu S. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China JAMA Intern Med 2020 10.1001/jamainternmed.2020.0994 

  29. 29 Lan L. Xu D. Ye G. Xia C. Wang S. Li Y. Positive RT-PCR test results in patients recovered from COVID-19 JAMA 27 2020 10.1001/jama.2020.2783 

  30. 30 Chung M. Bernheim A. Mei X. Zhang N. Huang M. Zeng X. CT imaging features of 2019 novel coronavirus (2019-nCoV) Radiology 2020 https://doi/10.1148/radiol.2020.200230 

  31. 31 Lei J. Li J. Li X. Qi X. CT Imaging of the novel coronavirus (2019-nCoV) Pneumonia Radiology 2020 https://doi/10.1148/radiol.2020200236 

  32. 32 kanne J.P. Chest CT findings in 2019 novel coronavirus (2019-nCoV) infections from Wuhan, China: key points for the radiologist Radiology 2020 https://doi:10.1148/radiol.2020200241 

  33. 33 Ai T. Yang Z. Hou H. Zhan C. Chen C. Lv W. Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases Radiology 2020 https://doi:10.1148/radiol.2020200642 

  34. 34 Li X. Xia L. Coronavirus disease 2019 (COVID-19): role of chest CT in diagnosis and management AJR Am J Roentgenol. 4 2020 1 7 10.2214/AJR.20.22954 

  35. 35 Dai W.C. Zhang H.W. Yu J. Xu H.J. Chen H. Luo S.P. ct imaging and differential diagnosis of COVID-19 Can Assoc Radiol J. 4 2020 10.1177/0846537120913033 

  36. 36 Cu Y.H. Dong J.H. An W.M. Lv X.Y. Yin X.P. Zhang J.Z. Clinical and computed tomographic imaging features of Novel Coronavirus Pneumonia caused by SARS-CoV-2 J Infect. 25 2020 10.1016/j.jinf.2020.02.017 

  37. 37 Xu X. Yu C. Qu J. Zhang L. Jiang S. Huang D. Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2 Eur J Nucl Med Mol Imaging. 2020 10.1007/s00259-020-04735-9 

  38. 38 Shi H. Jiang N. Cao Y. Zhang L. Jiang S. Huang D. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study Lancet Infect Dis. 28 2020 10.1016/S1473-3099(20)30086-4 

  39. 39 Pan L. Wang L. Huang X. How to face the novel coronavirus infection during the 22019-2020 epidemic: the experience of Sichuan Provincial People´s Hospital Intensive Care Med. 2020 https://doi:/10.1007/s00134-020-05964-0 

  40. 40 Huang Y. Wang S. Liu Y. Zhang Y. Zheng C. Zheng Y. A Preliminary Study on the Ultrasonic Manifestations of Peripulmonary Lesions of Non-Critical Novel Coronavirus Pneumonia (COVID-19) SSRN 2020 10.2139/ssrn.3544750 

  41. 41 Chan J.F. Yip C.C. To K.K. Tang T.H. Wong S.C. Leung K.H. Improved molecular diagnosis of COVID-19 by the novel, highly sensitive and specific COVID-19-RdRp/Hel real-time reverse transcription-polymerase chain reaction assay validated in vitro and with clinical specimens J Clin Microbiol. 4 2020 10.1128/JCM.00310-20 

  42. 42 Liu R. Han H. Liu F. Lv Z. Wu K. Liu Y. Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in Wuhan, China, from Jan to Feb 2020 Clin Chim Acta. 7 2020 10.1016/j.cca.2020.03.009 

  43. 43 Cordes A.K. Heim A. Rapid random access detection of the novel SARS-coronavirus-2 (SARS-CoV-2, previously 2019-nCoV) using an open access protocol for the Panther Fusion J Clin Virol. 2020 10.1016/j.jcv.2020.104305 

  44. 44 Han Y. Yang H. The transmission and diagnosis of 2019 novel coronavirus infection disease (COVID-19): A Chinese perspective J Med Virol. 2020 10.1002/jmv.25749 

  45. 45 Arabi Y.M. Fowler R. Hayden F.G. Critical care management of adults with community‑acquired severe respiratory viral infection Intensive Care Med. 46 2020 315 328 10.1007/s00134-020-05943-5 32040667 

  46. 46 Rodriguez A. Ferri C. Martin-Loeches I. Diaz E. Masclans J.R. Gordo F. Grupo Español de Trabajo Gripe A Grave (GETGAG)/Sociedad Española de Medicina Intensiva, Crítica y Unidades Coronarias (SEMICYUC) Working Group; 2009-2015 H1N1 SEMICYUC Working Group investigators. Risk factors for noninvasive ventilation failure in critically ill subjects with confirmed influenza infection Respir Care. 62 2017 1307 1315 10.4187/respcare.05481 28698265 

  47. 47 Alraddadi B.M. Qushmaq I. Al-Hameed F.M. Mandourah Y. Almekhlafi G.A. Jose J. Saudi Critical Care Trials G (2019). Noninvasive ventilation in critically ill patients with the Middle East respiratory syndrome Influenza Other Respir Viruses 13 2019 382 390 10.1111/irv.12635 30884185 

  48. 48 Ou X. Hua Y. Liu J. Gong C. Zhao W. Effect of high-flow nasal cannula oxygen therapy in adults with acute hypoxemic respiratory failure: a meta-analysis of randomized controlled trials CMAJ 189 2017 E260 E267 10.1503/cmaj.160570 28246239 

  49. 49 Oriol Roca1, Berta Caralt, Jonathan Messika, Manuel Samper, Benjamin Sztrymf, Gonzalo Hernández, Marina García-de-Acilu, Jean-Pierre Frat, Joan R. Masclans, Jean-Damien Ricard An index combining respiratory rate and oxygenation to predict outcome of nasal high flow therapy. AJRCCM 21-December-2018. http://doi:10.1164/rccm.201803-0589OC. 

  50. 50 Rochwerg B. Brochard L. Elliott M.W. Hess D. Hill N.S. Nava S. Raoof SMOTTF. Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure Eur Respir J. 31 2017 50 10.1183/13993003.02426-2016 

  51. 51 Manejo clínico de pacientes con enfermedad por el nuevo coronavirus (COVID-19). Documento técnico. Ministerio de Sanidad. Gobierno de España. 18 de febrero de 2020. https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov-China/documentos/Protocolo_manejo_clinico_COVID-19.pdf. [consultado el 27 de febrero de 2020]. 

  52. 52 Yang X. Yu Y. Xu J. Shu H. Xia J. Liu H. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study Lancet Respir Med 21 2020 10.1016/S2213-2600(20)30079-5 

  53. 53 Xu Y. Deng X. Han Y. Zhou L. He W. Chen S. A multicenter retrospective review of prone position ventilation (PPV) in treatment of severe human H7N9 avian flu PLoS One. 28 2015 10 10.1371/journal.pone.0136520 

  54. 54 Video: Coronavirus in Italy – Report From The Front Lines; Maurizio Cecconi, MD, talks with JAMA Editor Howard Bauchner, MD. [Ultimo acceso el 13 de marzo de 2020]. https://www.youtube.com/watch?v=TKS1pahoPRU&feature=youtu.be. 

  55. 55 Arabi Y.M. Balkhy H.H. Hayden F.G. Bouchama A. Luke T. Baillie J.K. Middle East respiratory syndrome N Engl J Med 376 2017 584 594 10.1056/NEJMsr1408795 28177862 

  56. 56 Nicholls J.M. Poon LLM Lee K.C. Ng W.F. Lai S.T. Leung C.Y. Lung pathology of fatal severe acute respiratory syndrome Lancet 361 2003 1773 1778 10.1016/s0140-6736(03)13413-7 12781536 

  57. 57 Tsang O.T. Chau T.N. Choi K.W. Tso E.Y. Lim W. Chiu M.C. Coronavirus-positive nasopharyngeal aspirate as predictor for severe acute respiratory syndrome mortality Emerg Infect Dis 9 2003 1381 1387 10.3201/eid0911.030400 14718079 

  58. 58 Arabi Y.M. Mandourah Y. Al-Hameed F. Sindi A.A. Almekhlafi G.A. Hussein M.A. Corticosteroid therapy for critically ill patients with middle east respiratory syndrome Am J Respir Crit Care Med 197 2018 757 767 10.1164/rccm.201706-1172OC 29161116 

  59. 59 World Health Organization. (2020). Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected: interim guidance, 28 January 2020. https://apps.who.int/iris/handle/10665/330893. [consultado el 27 de febrero de 2020]. 

  60. 60 Jin Y. Cai L. Cheng Z. Cheng H. Deng T. Fan Y.P. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version) Military Med Res 7 2020 4 10.1186/s40779-020-0233-6 

  61. 61 Jiang H. Deng H. Wang Y. Liu Z. Sun W.M. The possibility of using Lopinave/Litonawe (LPV/r) as treatment for novel coronavirus 2019-nCov pneumonia: a quick systematic review based on earlier coronavirus clinical studies Zhonghua Jizhen Yixue Zazhi. c29 2020 c182 186 10.3760/cma.j.issn.1671-0282.2020.02.0011 

  62. 62 Zhang Q. Wang Y. Qi C. Shen L. Li Jian Clinical trial analysis of 2019‐nCoV therapy registered in China J Med Virol 2020 10.1002/jmv.25733 

  63. 63 Yao X. Ye F. Zhang M. Cui C. Huang B. Niu P. In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Clinical Infectious Diseases 2020 10.1093/cid/ciaa237 

  64. 64 Xing Q. Li G. Xing Y. Chen T. Li W. Ni W. Precautions are needed for COVID-19 patients with coinfection of common respiratory pathogens medRXiv 2020 10.1101/2020.02.29.20027698 

  65. 65 WHO Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected Available at: https://www.who.int/publications-detail/infection-prevention-and-control-during-health-care-whennovel-coronavirus-(ncov)-infection-is-suspected. [consultado el 26 de febrero de 2020] 2020 

  66. 66 Loutfy M.R. Wallington T. Rutledge T. Mederski B. Rose K. Kwolek S. Hospital preparedness and SARS Emerg. Infect. Dis. 10 2004 771 776 10.3201/eid1005.030717 15200807 

  67. 67 WHO Hospital infection control guidance for Severe Acute Respiratory Syndrome (SARS) Available at: https://www.who.int/ihr/lyon/surveillance/infectioncontrol/en/. [consultado el 26 de febrero de 2020] 2005 

  68. 68 Jansson M. Liao X. Rello J. Strengthening ICU health security for a coronavirus epidemic Intensive Crit Care Nurs 2020 10.1016/j.iccn.2020.102812 

  69. 69 Protocolo institucional Hospital Universitario Marqués de Valdecilla. SISTEMA DE PREVENCION N24. Instrucción Preventiva-01 CODIGO: N24 (IP-01) REVISIÓN Nº: 4 ULTIMA REV: 6-MARZO-2020 CORONAVIRUS COVID-19 [consultado el 12 de marzo de 2020]. 

  70. 70 Respiratory care committee of Chinese Thoracic Society. Expert consensus on preventing nosocomial transmission during respiratory care for critically ill patients infected by 2019 novel coronavirus pneumonia [Article in Chinese; Abstract available in Chinese from the publisher]. Zhonghua Jie He He Hu Xi Za Zhi. 2020;17:E020, 10.3760/cma.j.issn.1001-0939.2020.0020 . 

  71. 71 Wax R.S. Christian M.D. Practical recommendations for critical care and anesthesiology teams caring for novel coronavirus (2019-nCoV) patients Can J Anaesth 12 2020 10.1007/s12630-020-01591-x 

  72. 72 Kang L. Li Y. Hu S. Chen M. Yang C. Yang B.X. The mental health of medical workers in Wuhan, China dealing with the 2019 novel coronavirus Lancet Psychiatry 7 3 2020 e14 10.1016/S2215-0366(20)30047-X 32035030 

관련 콘텐츠

오픈액세스(OA) 유형

BRONZE

출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로